Subscribe free

Newsletter

Metabolic and Bariatric Surgery

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
Surgeon23 Oct 2024

Consensus guidelines established for peri-operative care in obese patients

A modified Delphi process yielded 94 consensus statements on optimising peri-operative care for patients with obesity undergoing non-bariatric surgery. Key pre-operative strategies include access to prehabilitation and risk stratification tools, while intra-operative focus centres on the roles of anaesthetists and surgeons, minimally invasive techniques, and…

Surg Endosc17 Oct 2024

Predictive Factors for Postoperative Bleeding Identified

Analysis of nearly 1 million patients revealed specific factors predicting postoperative bleeding after minimally invasive bariatric surgeries. Key predictors identified include preoperative anticoagulation, renal insufficiency, history of deep vein thrombosis (DVT) and pulmonary embolism (PE), presence of a cardiac stent, and a BMI of 40…

Obes Surg14 Oct 2024

Fat Mass Index Effectively Predicts Weight Loss Post-Surgery

Fat mass index (FMI) significantly predicts early weight loss and quality of life following laparoscopic sleeve gastrectomy (LSG). In a study involving 243 patients, FMI demonstrated superior predictive ability compared to other body composition indicators, with an area under the curve of 0.813. Patients with…

Surg Obes Relat Dis12 Oct 2024

Same-day discharge for anastomotic bariatric surgeries shows promising outcomes

A study involving 208 patients from a high-volume Canadian center assessed early outcomes of same-day discharge (SDD) following various anastomotic metabolic and bariatric surgeries. Results demonstrated low rates of unplanned overnight stays, readmissions, and reinterventions. With a mean patient age of 41.4 years and a…

Surg Endosc3 Oct 2024

Endoscopic sleeve gastroplasty shows comparable outcomes to surgery

A retrospective analysis of patients undergoing endoscopic sleeve gastroplasty (ESG) versus laparoscopic sleeve gastrectomy (LSG) revealed similar improvements in obesity-related comorbidities. While LSG resulted in greater percentage total body weight loss at 6 months, 1 year, and 2 years, ESG was associated with shorter hospital…

Obes Surg3 Oct 2024

Machine learning models outperform traditional risk scores in bariatric surgery

Advanced machine learning techniques, particularly random forest, demonstrated superior performance in predicting 30-day complications in metabolic bariatric surgery compared to the established MBSAQIP risk score. The random forest model achieved an area under the receiver operating characteristic curve (AUROC) of 0.94 in training and 0.88…

Surg Obes Relat Dis19 Sep 2024

Preoperative anticoagulation increases postoperative morbidity in bariatric patients

A recent analysis of 1,178,090 patients reveals that those undergoing sleeve gastrectomy or Roux-en-Y gastric bypass with preoperative therapeutic anticoagulation face significantly higher risks of postoperative complications. Specifically, these patients exhibited increased rates of anastomotic leaks, deep vein thrombosis, and gastrointestinal bleeding, as well as…

Obes Surg19 Aug 2024

Probiotics enhance weight loss and eating behavior after surgery

Participants receiving probiotic supplementation alongside a weight loss program and cognitive behavioral therapy experienced significantly greater reductions in weight, body mass index, and fat mass compared to the placebo group (p 

J Gastrointest Surg17 Aug 2024

Metabolic and bariatric surgery significantly reduces insulin dependency in diabetes.

In a study of 287 patients with insulin-treated type 2 diabetes, metabolic and bariatric surgery (MBS) showed remarkable efficacy. At five years post-surgery, insulin dependence dropped from complete dependency to 36.2%, and the use of non-insulin antidiabetic drugs decreased from 79.4% to 26.1%. Additionally, type…

Obes Surg15 Aug 2024

Endoscopic sleeve gastroplasty shows cost-effectiveness for obesity treatment

Endoscopic sleeve gastroplasty (ESG) demonstrated cost-effectiveness compared to lifestyle modification in adults with class I/II obesity within a five-year horizon, achieving an incremental cost-effectiveness ratio of $23,432 per quality-adjusted life year (QALY). ESG remained cost-effective across sensitivity analyses and was dominant over longer timeframes. The…